==== Front J Dent (Shiraz) J Dent (Shiraz) Journal of Dentistry 2345-6485 2345-6418 Shiraz University of Medical Sciences Iran JDS-21-4 10.30476/DENTJODS.2019.77699.0 Case Report Childhood Systemic Lupus Erythematosus; a Rare Multisystem Disorder: Case Report of a 3-year-old Girl with Oral Involvement as a Primary Sign Horri Azadeh DMD, MScD1 Danesh Masume DMD, MScD2 Sadat Hashemipour Maryam DMD, MScD3 1 Oral and Dental Research Center, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran 2 Dept. of Pediatrics, Kerman University of Medical Sciences, Kerman, Iran 3 Dept. of Oral Health, Oral and Dental Research Center, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran Corresponding author: Danesh M, Dept. of Pediatrics, Kerman University of Medical Sciences, Kerman, Iran. Tel: +98-3432115780, Email: dr.masumedanesh@gmail.com 12 2020 21 4 338 342 9 6 2019 11 11 2018 15 4 2019 Copyright: © Journal of DentistryThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License, ( http://creativecommons.org/licenses/by/4.0/ ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Childhood-onset systemic lupus erythematosus (cSLE) is a severe, chronic, multi-organ, and systemic autoimmune disorder characterized by inflammatory and autoimmune reaction in several organs. The occurrence of systemic lupus erythematosus (SLE) in children is very rare. About 20% of all SLE cases are diagnosed during the first two decades of life and the disease is extremely rare before age of 5 years. In this case report, we present a 3-year-old girl presented with SLE symptoms similar to primary herpetic gingivostomatitis. Early diagnosis lead to proper treatment of the disease and it is important to decrease oral complications in children. Diagnosis could be improved by introduce new cases to provide valuable information for dentists based on diagnostic criteria, therapeutic steps and complication of treatment of SLE in Children. Therefore, it could be concluded that dentists involved in pediatric dentistry should consider and work out on the clinical signs of SLE in children with history of oral herpes virus infection. Systemic Lupus Erythematosus (SLE) Herpetic gingivostomatitis Autoimmune disorder ==== Body Introduction Childhood-onset systemic lupus erythematosus (cSLE) is a severe, chronic, multi-organ, systemic autoimmune disorder presented by inflammatory and autoimmune reaction in multiple organs [ 1 - 2 ]. Although the cSLE have the same pathophysiology compared to adult type SLE, but the initial clinical presentation of cSLE is observed more sever [ 3 - 8 ]. In addition, the abnormal appearance common in this age group is frequently responsible for major diagnostic delay [ 5 ]. Considering the most report series, the oral lesions are minor [ 4 - 10 ], therefore, they usually do not come to dental pediatric centers. The incidence of cSLE varies from 0.3 to 0.9 per 100,000 children-years [ 11 - 12 ]. It has been demonstrated that both renal and central nervous system (CNS) organs tend to be more involved in pediatric patients than in adults [ 13 - 14 ]. Only 20% of all patients with SLE are diagnosed during the first two decades of life and the disease is extremely rare in those below 5 years of age [ 1 , 15 ]. The diagnosis and treatment of patients with cSLE is based on the European evidence-based recommendations for diagnosis and treatment of cSLE [ 16 ]. Although several studies have reported the clinical and laboratory characteristics of patients with cSLE [ 1 , 3 , 17 ], based on literature review, there is no presentation of the disease in younger children (below 5 years of age). In this paper, we report a cSLE case of 3- year-' old girl, referred to Pediatric Department, Dental School, Medical University of Kerman, Iran, to provide a valuable information for dentists to improve diagnostic criteria, therapeutic steps in children with oral complications. Case Report A 3-year-old girl was referred to Pediatric Dentistry Department with severe white (keratotic) lesions on palate and buccal mucosa in oral cavity and lips along with odynophagia and inability to eat for three months. She had general gingival involvement and received analgesics and antibiotics including acetaminophen and Cefixime without any recovery. She had a history of malaise, fever, and fatigue at the onset of the disease along with weight loss (4 kg during 3 months). After one month, were observed that oral and facial lesions were gradually progressed. On physical examination, there was no lesion in the mucosa of eye and nose while a pale lesion on the face especially around the cheek and nose was observed. There were some cutaneous lesions on her scalp but no lesions on arms or legs. She had no history of primary gingivostomatitis. A positive family history (her grandfather and uncle) of rheumatoid arthritis was reported. The patient was the third and the last child of the family, being 15years younger than her siblings. There was no history of congenital disorders. Consultation with the Department of Diagnosis of Oral Diseases was carried out and according to the age of the child and acute oral symptoms, the primary diagnosis of the disease was established as primary herpetic gingivostomatitis according to epidemiology, clinical sign, and history. Based on response to the treatment regimen, other differential diagnoses including aphthous lesion, vesiculo bullous lesions, and Hand-Foot-Mouth disease were ruled out. The first impressions of patient were considered primary herpetic gingivostomatitis and the girl was treated with Nystatin suspension, Diphenhydramine, and Magnesium aluminum. The patient was followed up by supportive care and after 10 days, the oral aphthous lesions and the malar rash were exacerbated (Figure 1). Concerning the worsening of the lesions, further evaluations were scheduled. Subsequently by assessing the complete blood cell count and differential count (CBC &diff), biopsy of facial lesion (patient did not cooperate for oral lesion biopsy), and consultation with a rheumatologist, the SLE was diagnosed. Figure 1 Oral lesions, ulcer in hard palate and buccal mucosa Blood investigations revealed a hemoglobin concentration of 15.4 g/dL, and white blood cell count of 13.2× 109/L and platelet count of 486×109/L. The lymphocyte percentage was 58% compared to 35% neutrophil. Her erythrocyte sedimentation rate (ESR) was 31 mm at the first hour, and C-reactive protein (CRP) was positive. Her serum creatinine level was 0.52 mg/dL, and blood urea nitrogen (BUN) was 14 mg/dL. To rule out SLE and other collagen vascular diseases, the serologic tests showed positive antinuclear antibody (ANA), negative Anti-dsDNA and positive cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA). The serum level of C3-C4 complement fractions were reported normal (Table 1). Skin biopsy from the malar rash revealed non-specific chronic inflammation (dermatitis) with mononuclear cells without viral inclusion bodies. Table 1 Laboratory findings of patient Test Result Normal Value W.B.C 13000 4000-11000 R.B.C 5.02 4.3-5.2×106 Hemoglobin 13.5 12-16 Hematocrit 41 47-52 M.C.V 81.7 78-98 M.C.H 26.9 21-26 M.C.H.C 32.9 32-36 Platelet 386000 150000-400000 Creatinine 0.52 0.5-1.1 AST 37 15-45 ALT 20 15-45 ALKP 355 180-1200 ZN 71 70-120 ESR 31 0-20 CH50 90 101-300 Anti-dsDNA 9 +/- C3 1.58 83-177 mg/dl C4 0.35 15-45 mg/dl ANA 3.5 1.2 P-ANCA 1.2 - C-ANCA 10.6 - G6PD NORMAL - ANA-Screen 1.1 - CRP Quantitative 9 0/8-4 ALKP: alkaline phosphatase; ALT: Alanine Aminotransferase; ANA: antinuclear antibodies; AST: aspartate; Aminotransferase; CRP: C-reactive protein ESR: erythrocyte sedimentation rate; G6PD: Glucose-6-phosphate dehydrogenase; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; MCV: mean corpuscular volume; RBC: red blood cell; WBC: white blood cell Malar rash for face skin lesion was observed. In performed biopsy, the IgG and shaggy basement membrane zone was positive while IgM and C3 were negative. There was epidermal atrophy, mononuclear cell infiltration and orthokeratosis but there was no blister for mation. The pathologist differential diagnosis included lupus erythematosus and pemphigus vulgaris. After consultation with a neurologist and a nephrologist, it was confirmed that CNS and the renal system were not involved considering the normal urinalysis. Based on the clinical findings and the laboratory results (6 out of 11 criteria), the diagnosis of cSLE was confirmed regarding the American College of rheumatology (ACR) (Table 2) revised criteria for diagnosis of SLE [ 18 ]. The positive criteria included malar rash, oral ulcers, discoid rash (scalp lesions), photosensitivity in malar rash, antinuclear antibody, immunologic disorder (positive ANA, c-ANCA, and CRP). A rheumatologist was consulted and oral prednisolone (5 mg, twice daily) and oral hydroxychloroquine (5mg/kg once daily) was administered. The patient was followed up and after 10 days of therapy, the oral aphthous lesions were recovered and the malar rash disappeared (Figure 2). The patient was able to eat and drink and her weight increased after a month. In 6-month follow-up visit, there was no relapse and no lesion was detected. There was no renal and CNS involvement. The patient was recommended to continue the therapeutic regimen until 6 years of age. Relevant written consents have been obtained before publishing the case report. Table 2 The revised criteria for classification of systemic lupus erythematosus (1982) 1. Malar rash: Fixed erythema, flat or raised, over the malar eminences, tending to spare the nasolabial folds 2. Discoid rash: Erythematous raised patches with adherent keratotic scaling and follicular plugging; atrophic scarring may occur in older lesions: 3. Photosensitivity: Skin rash as a result of unusual reaction to sunlight, by patient history or physician observation 4. Oral ulcers: Oral or nasopharyngeal ulceration, usually painless, observed by physician 5. Arthritis: Nonerosive arthritis involving 2 or more peripheral joints, characterized by tenderness, swelling, or effusion 6. Serositis: a) Pleuritis--convincing history of pleuritic pain or rubbing heard by a physician or evidence of pleural effusion OR b) Pericarditis--documented by ECG or rub or evidence of pericardial effusion 7. Renal disorder: a) Persistent proteinuria greater than 0.5 grams per day or greater than 3+ if quantitation not performed OR b) Cellular casts--may be red cell, hemoglobin, granular, tubular, or mixed 8. Neurologic disorder: a) Seizures--in the absence of offending drugs or known metabolic derangements; e.g., uremia, ketoacidosis, or electrolyte im-balance OR b) Psychosis--in the absence of offending drugs or known metabolic derangements, e.g., uremia, ketoacidosis, or electrolyte imbalance 9. Hematologic disorder: a) Hemolytic anemia--with reticulocytosis OR b) Leukopenia--less than 4,000/mm3total on 2 or more occasions OR c) Lyphopenia--less than 1,500/mm3on 2 or more occasions OR d) Thrombocytopenia--less than 100,000/mm3in the absence of offending drugs 10. Immunologic disorder: a) Positive LE cell preparation OR b) Anti-DNA: antibody to native DNA in abnormal titer OR c) Anti-Sm: presence of antibody to Sm nuclear antigen OR d) False positive serologic test for syphilis known to be positive for at least 6 months and confirmed by Treponema pallidum immobilization or fluorescent treponemal antibody absorption test 11. Antinuclear antibody: An abnormal titer of antinuclear antibody by immunofluorescence or an equivalent assay at any point in time and in the absence of drugs known to be associated with "drug-induced lupus" syndrome Figure 2 a: Gingival lesion was recovered, b: The oral aphthous lesions of the patient after 10 days of conservative therapy, c: Pallor malar rash Discussion Infantile SLE is an extremely rare and to the best of our knowledge, only 13 cases have been reported in the world [ 19 - 20 ] (Table 3). The clinical course of the cSLE is progressive and associated with more severe symptoms and more progressive course with permanent sequellae [ 1 , 3 , 14 ]. Of the 14 patients reported in the literature, 5 died and 6 developed end-stage renal failure and complication of the CNS. It has been previously demonstrated that the prognosis of infantile SLE with high-grade glomerulonephritis is poor [ 19 , 21 - 22 ]. It is interesting that our patient had a benign course and did not have any evidence of lupus nephritis or involvement of the CNS. Evidence for a genetic predisposition to SLE in humans is based on the concordance rate (23%-57%) saw in indistinguishable twins and on the relative high frequency of familial cases (8%-12%). Candidate genes or loci for SLE liability have been located on the long-arm of chromosome 1 [ 23 ]. Our case had a family history of rheumatoid arthritis for her grandfather and uncle. Previously, Zulian et al. [ 20 ] demonstrated that infantile SLE had a more progressive course and was associated with more destructive symptoms than adult SLE. They also reported anemia and thrombocytopenia as frequent findings in infantile SLE, whereas eucopenlia was rare. Conversely, leukocytosis has been reported to be more common in infantile SLE [ 3 , 20 ]. In our case, there was no anemia and thrombocytopenia but the patient had leukocytosis in which the lymphocyte was more dominant. These hematological abnormalities, together with positive ANA and decreased C3-C4 complement fractions, should address the diagnosis of SLE in young children with unexplained fever, irritability, and rash. However, since positive ANA and hypocomplementemia may be because of concomitant infections, these findings have low specificity as diagnostic tools, especially, in this age group, where SLE has a very low prevalence [ 20 ]. Currently, intravenous cyclophosphamide (IVCY) therapy is considered the standard treatment for both children and adults with severe lupus nephritis [ 16 ]. However, in our patient, as there was no evidence of lupus nephritis, we did not administer the IVCY. The efficacy of IVCY in treatment of infantile SLE is yet to be identified. There are only two previous reports of successful IVCY treatment, in infantile SLE with lupus-nephritis [ 19 , 22 ]. Table 3 Previous reports of cSLE Reference No [24] [25] [26] [27] [28] [29] [16] Patient No 1 2 3 4 6 7 8 Age at onset (months) 11 2.5 5 9 3 3 8 Sex F F F F F M M Race African-American Caucasian Caucasian Caucasian Caucasian Caucasian Caucasian Signs and symptoms at disease onset Fever, Rash Alopecia Oral ulcers Fever, Serositis Edema Rash Hypertonia, RASH Fever Fever, Diarrhea Irritability Purpuric Rash Oral ulcers Irritability Purpuric Rash Oral ulcers First diagnosis Multiforme erythema SLE DIC DIC SLE SLE SLE DIC=disseminated intravascular coagulation ; SLE= systemic lupus erythematosus As recommended by the European evidence-based recommendations for diagnosis and treatment of cSLE, corticosteroids remain the mainstay of the treatment of infantile and cSLE. All the previously reported cases received high dosages of prednisolone with different responses [ 3 , 19 - 22 ]. In the current report, we observed significant and abrupt response of the symptoms to the initial dose of prednisolone. However, in previously reported cases, the response to the corticosteroids were limited and thus adding other agents were required [ 3 , 19 - 20 ]. In brief, the rare case of infantile SLE can be treated successfully treated with oral prednisolone. Timely diagnosis and treatment is the key step in treatment of cSLE. The diagnosis in this age group should be based on the clinical suspicion. Conclusion Since cSLE is extremely rare in individuals younger than 5 years of age, and concerning the oral symptoms of SLE in children, dentists' awareness of these symptoms leads to earlier diagnosis and therefore better treatment. Acknowledgement We would like to thank the patient and her family who participated in this study. We also thank to Dr. Shakibi, Dr. Ataei, and Dr. Sharifi Moghadam for their valuable cooperation. Conflict of Interest: None declared. ==== Refs References 1 Hiraki LT Benseler SM Tyrrell PN Hebert D Harvey E Silverman ED Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study J Pediatr 2008 152 550 556 18346514 2 Komvilaisak P Wisanuyotin S Jettrisuparb A Wiangnon S Lupus Anticoagulant-hypoprothrombinemia Syndrome (LAC-HPS) in Children With Systemic Lupus Erythematosus: Report of 3 Cases J Pediatr Hematol Oncol 2017 39 e521 e524 28787393 3 Pluchinotta FR Schiavo B Vittadello F Martini G Perilongo G Zulian F Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes Lupus 2007 16 550 555 17711887 4 Carreño L López-Longo FJ Monteagudo I Rodríguez-Mahou M Bascones M González CM et al Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus Lupus 1999 8 287 292 10413207 5 Cervera R Khamashta MA Font J Sebastiani GD Gil A Lavilla P et al Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus Medicine (Baltimore) 1993 72 113 124 8479324 6 Costallat LT Coimbra AM Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset Clin Exp Rheumatol 1994 12 603 607 7895393 7 Font J Cervera R Espinosa G Pallarés L Ramos-Casals M Jiménez S et al Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults Ann Rheum Dis 1998 57 456 459 9797549 8 Tucker LB Menon S Schaller JG Isenberg DA Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome Br J Rheumatol 1995 34 866 872 7582729 9 Barron KS Silverman ED Gonzales J Reveille JD Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus Arthritis Rheum 1993 36 348 354 8452580 10 Marson P Rondinone R Vicarioto M Malar rash in a painting by Jean-Baptiste Siméon Chardin (1699-1779) Reumatismo 2001 53 175 179 12163893 11 Hiraki LT Feldman CH Liu J Alarcón GS Fischer MA Winkelmayer WC Costenbader KH Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population Arthritis Rheum 2012 64 2669 2676 22847366 12 Kamphuis S Silverman ED Prevalence and burden of pediatric-onset systemic lupus erythematosus Nat Rev Rheumatol 2010 6 538 546 20683438 13 Appenzeller S Marini R Costallat LT Damage did not independently influence mortality in childhood systemic lupus erythematosus Rheumatol Int 2005 25 619 624 15703958 14 Houghton KM Page J Cabral DA Petty RE Tucker LB Systemic lupus erythematosus in the pediatric North American Native population of British Columbia J Rheumatol 2006 33 161 163 16395763 15 Li AW Weed JG Stamey CR Subtil A Tomayko MM Antaya RJ Bullous systemic lupus erythematosus in a 6-year-old boy Pediatr Dermatol 2017 34 e313 e316 28851077 16 Groot N Graeff N Avcin T Bader-Meunier B Brogan P Dolezalova P et al European evidence-based recommenddations for diagnosis and treatment of childhood- onset systemic lupus erythematosus: the SHARE initiative Ann Rheum Dis 2017 14 183 185 17 Nazarinia MA Ghaffarpasand F Shamsdin A Karimi AA Abbasi N Amiri A Systemic lupus erythematosus in the Fars Province of Iran Lupus 2008 17 221 227 18372364 18 Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1997 40 1725 19 Kishi N Suga K Matsuura S Kinoshita Y Urushihara M Kondo S et al A case of infantile systemic lupus erythematosus with severe lupus nephritis and EBV infection CEN Case Rep 2013 2 190 193 28509290 20 Zulian F Pluchinotta F Martini G Da Dalt L Zacchello G Severe clinical course of systemic lupus erythematosus in the first year of life Lupus 2008 17 780 786 18755858 21 Kreindler J Ellis D Vats A Kurland G Ranganathan S Moritz ML Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage Pediatr Nephrol 2005 20 522 525 15717168 22 Saberi MS Jones BA Remission of infantile systemic lupus erythematosus with intravenous cyclophosphamide Pediatr Nephrol 1998 12 136 138 9543373 23 Michel M Johanet C Meyer O Francès C Wittke F Michel C et al Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families Medicine (Baltimore) 2001 80 153 158 11388091 24 Grossman J Schwartz RH Callerame ML Condemi JJ Systemic lupus erythematosus in a 1-year-old child Am J Dis Child 1975 129 123 125 1130330 25 Jordan SC Lemire JM Border W Sakai R Ettenger RB Fine RN False-negative anti-DNA antibody activity in infantile systemic lupus erythematosus (SLE) J Clin Immunol 1984 4 156 162 6609934 26 Anderson JR Intracerebral calcification in a case of systemic lupus erythematosus with neurological manifestations Neuropathol Appl Neurobiol 1981 7 161 166 7231643 27 Jordan JM Valenstein P Kredich DW Systemic lupus erythematosus with Libman-Sachs endocarditis in a 9-month-old infant with neonatal lupus erythematosus and congenital heart block Pediatrics 1989 84 574 578 2671916 28 Massengill SF Richard GA Donnelly WH Infantile systemic lupus erythematosus with onset simulating congenital nephrotic syndrome J Pediatr 1994 124 27 31 8283373 29 Cummings NP Hansen J Hollister JR Systemic lupus erythematosus in a premature infant Arthritis Rheum 1985 28 573 575 3873944